Sorry, your browser doesn't support embedded videos.
Get in touch now
Home | Continuous manufacturing cautiously builds on hype
In this issue
The pharma industry briefing
Covid-19 executive briefing by GlobalData
SHL Medical Company Insight
CMO agreements need to go public, but ‘glib’ onshoring not the answer
Biologic sales forecast to pass innovative small molecule sales in next five yea
The telemedicine community has rallied to provide support to patients in Ukraine
Osteoarthritis pipeline shifting from analgesics to disease-modifying treatments
Mimotopes Company Insight
Continuous manufacturing builds on hype but adoption remains gradual
Can Relmada’s fast-acting pill for major depressive disorder compete in
Access to CAR-T therapies in Central and Eastern Europe in “catch-up” mode compa
How ambitious are the emissions targets of pharma and biotech companies?
Should Covid-19 clinical trial plans still centre around EUAs?
Datwyler Company Insight
Top and emerging locations for M&A deals in the pharma industry
Deals relating to genomics increased in the pharma industry in H2 2021
Pharma industry companies are increasingly innovating in machine learning